Deletion of the steroid 21-hydroxylase and complement C4 genes in congenital adrenal hyperplasia
Abstract:
DNA was analysed from 20 patients with congenital adrenal hyperplasia due to cytochrome P-450 steroid 21-hydroxylase deficiency. Using probes recognising sequences in both the 21-hydroxylase gene and the adjacent fourth component of complement (C4), one patient was found to have a homozygous deletion of DNA which encompassed the C4B and 21-hydroxylase B genes. Evidence is presented for this deletion arising by recombination between homologous regions of 21-hydroxylase A and B. Seven patients appeared to be heterozygous for the same deletion, but no detectable alteration in the 21-hydroxylase gene could be demonstrated in others.
Insights
Genetic analysis of 20 congenital adrenal hyperplasia patients revealed a homozygous deletion of the C4B and 21-hydroxylase B genes in one individual. This deletion likely resulted from recombination between 21-hydroxylase A and B gene regions.
Area of Science:
- Genetics
- Molecular Biology
- Endocrinology
Background:
- Congenital adrenal hyperplasia (CAH) is a group of genetic disorders affecting adrenal steroid production.
- Cytochrome P-450 steroid 21-hydroxylase deficiency is the most common cause of CAH.
- The 21-hydroxylase gene and the fourth component of complement (C4) gene are located in close proximity on chromosome 6p21.3.
Purpose of the Study:
- To investigate the genetic basis of 21-hydroxylase deficiency in patients with CAH.
- To identify potential DNA deletions or rearrangements involving the 21-hydroxylase gene and the adjacent C4 gene.
Main Methods:
- DNA analysis was performed on 20 patients diagnosed with CAH.
- Probes specific to the 21-hydroxylase gene and the C4 gene were utilized.
- Southern blot hybridization was employed to detect DNA deletions and rearrangements.
Main Results:
- One patient presented with a homozygous deletion encompassing both the C4B and 21-hydroxylase B genes.
- Evidence suggests this deletion arose from unequal crossing-over between homologous regions of the 21-hydroxylase A and B genes.
- Seven additional patients were found to be heterozygous for the same deletion.
Conclusions:
- The study identified a specific DNA deletion associated with 21-hydroxylase deficiency in CAH patients.
- Recombination between homologous 21-hydroxylase gene regions is a plausible mechanism for generating such deletions.
- Further investigation is warranted to understand the clinical implications of heterozygous deletions.
Related Concept Videos
Pleiotropy
X-Inactivation
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cushing Syndrome I: Introduction
Cushing Syndrome II: Pathophysiology


